Results 221 to 230 of about 775,328 (297)

Supplementary Figure S4 from Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non–Small Cell Lung Cancer

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, J. L. Gonz�lez Larriba, Alex Martínez-Martí, Reyes Bernabé Caro, Joaquim Bosch-Barrera, Virginia Calvo, Amelia Insa Molla, Noemí Reguart, Javier de Castro Carpeño, Carlos Aguado de la Rosa, Ramon Palmero Sanchez, Florentino Hernando Trancho, Javier Martn-Lpez, Alejandro Rodríguez-Festa, Pilar Mediavilla-Medel, Martín Lázaro, Jim Hayes, Alberto Cruz-Bermúdez, Bartomeu Massutí, Atocha Romero   +21 more
openalex   +1 more source

Additional file 4: Figure S3. of Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis

, 2017
Ying-Jun Chang, Yu Wang, Yan-Rong Liu, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Jingzhi Wang, Wei Han, Yu-Qian Sun, Chen‐Hua Yan, Feifei Tang, Xiao-Dong Mo, Kai-Yan Liu, Xiao-Jun Huang   +14 more
openalex   +1 more source

Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models. [PDF]

Nat Commun
Ott CA, Purwin TJ, Chen PY, Chowdhury S, Mellor GL, Luo K, Mersky GL, Tiago M, Madden WD, Varney SD, Erkes DA, Lamar J, Capparelli C, Bollag G, Aplin AE.   +14 more
europepmc   +1 more source

Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide

, 1990
Tomasz Skórski, Maciej Kawalec, J Kawiak   +2 more
openalex   +2 more sources

Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma. [PDF]

Cancers (Basel)
Boldrin E, Piano MA, Volpato A, Alfieri R, Franco M, Morbin T, Masier A, Realdon S, Mattara G, Magni G, Rosato A, Pilati P, Fantin A, Curtarello M.   +13 more
europepmc   +1 more source

The Impact of Minimal Residual Disease Measurement in the Management of Chronic Lymphocytic Leukemia. [PDF]

Cancers (Basel)
Greenberg MR, Lucido T, Singh K, Rhodes JM.   +3 more
europepmc   +1 more source

Correction to: Prognostic value of dynamic minimal residual disease monitoring for adolescent and adult T-lymphoblastic leukemia/lymphoma. [PDF]

Ann Hematol
Yang Y, Zhang X, Jiang N, Jin Y, Liu Y, Liao H.   +5 more
europepmc   +1 more source

Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL [PDF]

, 2018
Bartlett, Nancy L.
core   +1 more source

Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma. [PDF]

Sci Rep
Bauer F, Hajiyianni M, Weinhold N, Grözinger M, Kächele J, Menis E, Raab MS, Sauer S, Jauch A, Weber TF, Debic M, Besemer B, Horger M, Afat S, Hoffmann M, Hoffend J, Kraemer D, Graeven U, Ringelstein A, Dürig J, Umutlu L, Schlemmer HP, Goldschmidt H, Maier-Hein K, Delorme S, Mai EK, Wennmann M, Neher P.   +27 more
europepmc   +1 more source

16. Minimal Residual Disease

Annals of Oncology, 2002
openaire   +1 more source